Top Markets
Coin of the day
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
Rank in Stocks #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Share Price
$0.41
Last synced: 2025-01-23
Market Cap
$1.08M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade CohBar, Inc. (CWBR)

Category

Stock price history for CohBar, Inc. (CWBR)
Highest end of day price: $0.41 on 2025-01-01

Lowest end of day price: $40.85 on 2015-01-01
Stock price history of CohBar, Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2025 -20.04%
2024 -31.92%
2023 -55.78%
2022 -86.40%
2021 -68.20%
2020 -20.77%
2019 -51.89%
2018 -32.62%
2017 143.41%
2016 80.68%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE